Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fogelman

Showing results (41-50 of 334) with videos related to

Pageof 34
Sort By:
European Journal of Nuclear Medicine|January 1, 1981
The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in ratsI Fogelman, R G Bessent
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 18, 2001
Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomographyG J Cook, I Fogelman
Current Pharmaceutical Design|August 13, 2002
The role of bone density measurements in the evaluation of new treatments for osteoporosisG M Blake, I Fogelman
Current Opinion in Rheumatology|April 1, 1990
Densitometry and bone mineral measurementC R Wilson, I Fogelman
Seminars in Nuclear Medicine|February 24, 2001
Bone densitometry and the diagnosis of osteoporosisG M Blake, I Fogelman
Radiology|March 1, 1994
Osteoporotic vertebral fractures: diagnosis with radiography and bone scintigraphyP J Ryan, I Fogelman
Clinical Rheumatology|September 1, 1994
Clinical experience with etidronate in osteoporosisP J Ryan, I Fogelman
British Journal of Hospital Medicine|June 1, 1985
Nuclear medicine: a clinical serviceI Fogelman, M N Maisey
European Journal of Nuclear Medicine|September 2, 1998
Bone scanning in clinical oncology: does it have a future?A F Jacobson, I Fogelman
Annals of Internal Medicine|August 1, 1979
Renal excretion of technetium-99m diphosphonate in osteomalaciaI Fogelman, R G Bessent
Pageof 34

Showing results (41-50 of 334) with videos related to

Sort By:
Pageof 34
European Journal of Nuclear Medicine|January 1, 1981
The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in ratsI Fogelman, R G Bessent
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 18, 2001
Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomographyG J Cook, I Fogelman
Current Pharmaceutical Design|August 13, 2002
The role of bone density measurements in the evaluation of new treatments for osteoporosisG M Blake, I Fogelman
Current Opinion in Rheumatology|April 1, 1990
Densitometry and bone mineral measurementC R Wilson, I Fogelman
Seminars in Nuclear Medicine|February 24, 2001
Bone densitometry and the diagnosis of osteoporosisG M Blake, I Fogelman
Radiology|March 1, 1994
Osteoporotic vertebral fractures: diagnosis with radiography and bone scintigraphyP J Ryan, I Fogelman
Clinical Rheumatology|September 1, 1994
Clinical experience with etidronate in osteoporosisP J Ryan, I Fogelman
British Journal of Hospital Medicine|June 1, 1985
Nuclear medicine: a clinical serviceI Fogelman, M N Maisey
European Journal of Nuclear Medicine|September 2, 1998
Bone scanning in clinical oncology: does it have a future?A F Jacobson, I Fogelman
Annals of Internal Medicine|August 1, 1979
Renal excretion of technetium-99m diphosphonate in osteomalaciaI Fogelman, R G Bessent
Pageof 34